Different routes of administration are conceivable, for example, topical applications of combined H1R/H2R antagonists in dermatology or systemic administration for premedication in anaesthesia and surgery or for the prevention of hypersensitivity reactions to drug treatment, e.g., in cancer chemotherapy. Here, HRH1 is linked to cancer.